ProductsBack/Cytokeratin 18 antibody [N2C2], Internal

Cytokeratin 18 antibody [N2C2], Internal

Name: Cytokeratin 18 antibody [N2C2], Internal
SKU: GTX105624_G10
Availability: BackOrder

GTX105624

ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Product group Antibodies

TargetKRT18

Overview

Supplier
GeneTex
Product Name
Cytokeratin 18 antibody [N2C2], Internal
Delivery Days Customer
9
Application Supplier Note
WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Applications
ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Certification
Research Use Only
Clonality
Polyclonal
Concentration
0.54 mg/ml
Conjugate
Unconjugated
Gene ID3875
Target name
KRT18
Target description
keratin 18
Target synonyms
CK-18, CYK18, K18, keratin, type I cytoskeletal 18, cell proliferation-inducing gene 46 protein, cytokeratin 18, keratin 18, type I
Host
Rabbit
Isotype
IgG
Protein IDP05783
Protein Name
Keratin, type I cytoskeletal 18
Scientific Description
KRT18 encodes the type I intermediate filament chain keratin 18. Keratin 18, together with its filament partner keratin 8, are perhaps the most commonly found members of the intermediate filament gene family. They are expressed in single layer epithelial tissues of the body. Mutations in this gene have been linked to cryptogenic cirrhosis. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq]
Storage Instruction
-20°C or -80°C,2°C to 8°C
UNSPSC
12352203

Wuputra K, Hsiao PJ, Chang WT, et al. FOXM1-CD44 Signaling Is Critical for the Acquisition of Regorafenib Resistance in Human Liver Cancer Cells. Int J Mol Sci. 2022,23(14). doi: 10.3390/ijms23147782
Read this paper
Yu HI, Chou HC, Su YC, et al. Proteomic analysis of evodiamine-induced cytotoxicity in thyroid cancer cells. J Pharm Biomed Anal. 2018,160:344-350. doi: 10.1016/j.jpba.2018.08.008
Read this paper
Luni C, Giulitti S, Serena E, et al. High-efficiency cellular reprogramming with microfluidics. Nat Methods. 2016,13(5):446-52. doi: 10.1038/nmeth.3832
Read this paper
Sundararaman B, Zhan L, Blue SM, et al. Resources for the Comprehensive Discovery of Functional RNA Elements. Mol Cell. 2016,61(6):903-13. doi: 10.1016/j.molcel.2016.02.012
Read this paper
Xing C, Ci X, Sun X, et al. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways. Neoplasia. 2014,16(11):883-99. doi: 10.1016/j.neo.2014.09.006
Read this paper